| Dr Stephen C Ume, MD | |
|
3840 Peachtree Industrial Blvd Ste 100, Duluth, GA 30096-5032 | |
| (678) 585-1901 | |
| (678) 691-2138 |
| Full Name | Dr Stephen C Ume |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 3840 Peachtree Industrial Blvd Ste 100, Duluth, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558312462 | NPI | - | NPPES |
| 274701400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME94281 (Florida) | Secondary |
| 208D00000X | General Practice | 89092 (Georgia) | Secondary |
| 207W00000X | Ophthalmology | 89092 (Georgia) | Primary |
| Entity Name | Gwinnett Ophthalmology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053061747 PECOS PAC ID: 9830576248 Enrollment ID: O20220524001010 |
News Archive
Advanced Cell Technology, Inc. announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November. The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues.
Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year.
Researchers at the UC San Diego School of Medicine have demonstrated for the first time that veterans of the 1990-91 Persian Gulf War who suffer from "Gulf War illness" have impaired function of mitochondria - the energy powerhouses of cells.
Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.
In a continuing effort to build a more sustainable business, OMNOVA Solutions today announced a price increase of up to $0.05/wet lb. ($0.10/dry lb.) on all styrene butadiene latex products to all served markets in the Americas.
› Verified 5 days ago
| Entity Name | Gwinnett Urgent Eye Care Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013786458 PECOS PAC ID: 1759734676 Enrollment ID: O20240126003507 |
News Archive
Advanced Cell Technology, Inc. announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November. The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues.
Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year.
Researchers at the UC San Diego School of Medicine have demonstrated for the first time that veterans of the 1990-91 Persian Gulf War who suffer from "Gulf War illness" have impaired function of mitochondria - the energy powerhouses of cells.
Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.
In a continuing effort to build a more sustainable business, OMNOVA Solutions today announced a price increase of up to $0.05/wet lb. ($0.10/dry lb.) on all styrene butadiene latex products to all served markets in the Americas.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen C Ume, MD 3840 Peachtree Industrial Blvd Ste 100, Duluth, GA 30096-5032 Ph: (678) 585-1901 | Dr Stephen C Ume, MD 3840 Peachtree Industrial Blvd Ste 100, Duluth, GA 30096-5032 Ph: (678) 585-1901 |
News Archive
Advanced Cell Technology, Inc. announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November. The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues.
Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year.
Researchers at the UC San Diego School of Medicine have demonstrated for the first time that veterans of the 1990-91 Persian Gulf War who suffer from "Gulf War illness" have impaired function of mitochondria - the energy powerhouses of cells.
Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.
In a continuing effort to build a more sustainable business, OMNOVA Solutions today announced a price increase of up to $0.05/wet lb. ($0.10/dry lb.) on all styrene butadiene latex products to all served markets in the Americas.
› Verified 5 days ago
Dennis P Breene, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2070 Pleasant Hill Rd Ste 100, Duluth, GA 30096 Phone: 770-622-2020 | |
Dr. Monica Y. Allen, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3650 Steve Reynolds Blvd., Kaiser Permanente Gwinnett Medical Center, Duluth, GA 30096 Phone: 313-577-8900 | |
Dr. William A Segal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3800 Pleasant Hill Rd, Suite 3, Duluth, GA 30096 Phone: 678-584-0400 Fax: 678-584-0568 | |
Dr. Junhee Lee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2070 Pleasant Hill Rd # 100, Duluth, GA 30096 Phone: 770-662-2020 Fax: 470-545-2261 | |
Polly A Henderson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3650 Steve Reynolds Blvd, Kaiser Permanente Gwinnett Medical Center, Duluth, GA 30096 Phone: 215-762-3937 Fax: 215-762-5600 | |
Dr. Patrick Joseph Danaher, M.D Ophthalmology Medicare: Medicare Enrolled Practice Location: 11315 Johns Creek Pkwy Ste 300, Duluth, GA 30097 Phone: 678-381-2020 |